Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Kudva: Randomized controlled clinical trial of glargine versus ultralente insulin in the.... (0.09 sec) 

Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of …


YC Kudva, A Basu, GD Jenkins, GM Pons, LL … - Diabetes care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—To determine whether the use of glargine insulin
as a basal insulin would result in a comparable HbA 1c and less glycemic
variation and hypoglycemia than ultralente insulin, 22 individuals (aged 44 ...
Cited by 27 - Related articles - All 7 versions

An observational study comparing continuous subcutaneous insulin infusion (CSII) and …


R Schiaffini, P Ciampalini, S Spera, M Cappa, … - Diabetes/Metabolism Reviews - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 26 - Related articles - All 3 versions

Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 …


SK Garg, JM Paul, JI Karsten, L Menditto, PA … - Diabetes Technology & Therapeutics, 2004 - liebertonline.com
Page 1. DIABETES TECHNOLOGY & THERAPEUTICS Volume 6, Number 5, 2004 © Mary Ann Liebert,
Inc. Reduced Severe Hypoglycemia with Insulin Glargine in ...
Cited by 21 - Related articles - BL Direct - All 3 versions

Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and …


GR Fulcher, RE Gilbert, DK Yue - Internal Medicine Journal, 2005 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 45 - Related articles - BL Direct - All 4 versions

Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily …


R Alemzadeh, JN Ellis, MK Holzum, EA Parton … - Pediatrics, 2004 - Am Acad Pediatrics
Results. The total daily insulin dose did not change in CSII (0.97 ± 0.24 vs
0.91 ± 0.22 U/kg) and FMDI (0.98 ± 0.21 vs 0.97 ± 0.21 U/kg) patients,
whereas the bolus:basal insulin ratio was significantly increased in both ...
Cited by 41 - Related articles - BL Direct - All 5 versions

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using …


TR Pieber, HC Treichel, B Hompesch, A … - Diabetic Medicine, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 44 - Related articles - BL Direct - All 5 versions

Better long-term glycaemic control with the basal insulin glargine as compared with NPH in …


F Porcellati, P Rossetti, S Pampanelli, CG … - Diabetic Medicine, 2004 - interscience.wiley.com
Methods One hundred and twenty-one patients with T1 DM on intensive therapy on
four times/day NPH and lispro insulin at each meal, were randomized to either
continuation of NPH four times/day (n = 60), or once daily glargine at ...
Cited by 106 - Related articles - BL Direct - All 4 versions

Once-daily insulin glargine compared with twice-daily NPH insulin in patients with type 1 …


KS Hershon, TC Blevins, TC Blevins, TC … - Endocrine Practice, 2004 - AACE
In patients with diabetes, good glycemic control has been shown to prevent or
delay microvascular complica- tions (1,2). Several studies have demonstrated
that decreasing glycosylated hemoglobin (HbA1c) levels to 7.0% (normal, 2.8 ...
Cited by 33 - Related articles - BL Direct - All 2 versions

The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy …


E Standl, H Lang, A Roberts - Diabetes technology & therapeutics, 2004 - liebertonline.com
EBERHARD STANDL, MD,1 HANNE LANG, M.Sc.,2 and ANTHONY ROBERTS, MD3 ...
Background: This trial compared the long-term safety and efficacy of the basal
insulin prepa- rations, insulin detemir and NPH insulin, in basal-bolus ...
Cited by 85 - Related articles - BL Direct - All 3 versions

Insulin detemir--a new basal insulin analog


JD Goldman-Levine, KW Lee - The Annals of pharmacotherapy, 2005 - Harvey Whitney Books
Published Online, 18 January 2005, www.theannals.com, DOI 10.1345/aph.1E334. The
Annals of Pharmacotherapy: Vol. 39, No. 3, pp. 502-507. DOI 10.1345/aph.1E334 ©
2005 Harvey Whitney Books Company. ... OBJECTIVE: To review the ...
Cited by 26 - Related articles - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google